SCHEMBL5508038

SCHEMBL5508038

COC(=O)[C@H]1CN(c2ccc3c(c2)CC(=O)N3CC(C)C)C(=O)O1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
BMPR1B O00238 1/20 0.38
BMPR1A P36894 1/20 0.38
TGFBR1 P36897 1/20 0.38
ACVRL1 P37023 1/20 0.38
ACVR1 Q04771 1/20 0.38
GAA P10253 1/20 0.36
MAOA P21397 3/20 0.36
KMT2A Q03164 3/20 0.35
BRD4 O60885 1/20 0.35
MAOB P27338 2/20 0.35
LMNA P02545 1/20 0.35
PTGS1 P23219 1/20 0.35
CALML3 P27482 1/20 0.35
SDHA P31040 1/20 0.35
GRM2 Q14416 2/20 0.34
MEN1 O00255 1/20 0.34
ATM Q13315 1/20 0.34
CES2 O00748 1/20 0.34
F10 P00742 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5505136 1.00 BMPR1B (0.38) BMPR1BBMPR1ATGFBR1ACVRL1ACVR1
SCHEMBL5503015 0.89 BRD4 (0.41) BMPR1BBMPR1ATGFBR1ACVRL1ACVR1
SCHEMBL5505721 0.89 MAOA (0.46) BMPR1BBMPR1ATGFBR1ACVRL1ACVR1
SCHEMBL5505719 0.89 MAOA (0.46) BMPR1BBMPR1ATGFBR1ACVRL1ACVR1
SCHEMBL5508961 0.88 BMPR1B (0.38) BMPR1BBMPR1ATGFBR1ACVRL1ACVR1
SCHEMBL5999288 0.87 GRM2 (0.39) BMPR1BBMPR1ATGFBR1ACVRL1ACVR1
SCHEMBL5517629 0.87 GRM2 (0.39) BMPR1BBMPR1ATGFBR1ACVRL1ACVR1
SCHEMBL5999250 0.86 MAOA (0.38) MAOAMAOBLMNAPTGS1CALML3
SCHEMBL5998454 0.85 MAOA (0.37) BMPR1BBMPR1ATGFBR1ACVRL1ACVR1
SCHEMBL5508240 0.83 GRM2 (0.36) BMPR1BBMPR1AACVRL1ACVR1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1781642-A1 OXAZOLIDINONES CONTAINING OXINDOLES AS ANTIBACTERIAL AGENTS Pharmacia & Upjohn Company LLC (US) 2007-05-09 EP disclosed
WO-2006016221-A1 OXAZOLIDINONES CONTAINING OXINDOLES AS ANTIBACTERIAL AGENTS PHARMACIA & UPJOHN COMPANY LLC (US) 2006-02-16 WO disclosed
US-20060030609-A1 Oxazolidinones containing oxindoles as antibacterial agents LUEHR GARY W 2006-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060030609-A1 Oxazolidinones containing oxindoles as antibacterial agents OXA1L, OXSR1, OXER1 BMPR1B 3285/4885BMPR1A 2586/4885TGFBR1 3517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.